SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Elghetany MT. Surface marker abnormalities in myelodysplastic syndromes. Haematologica 1998; 83: 11041115.
  • 2
    Loken MR, van de Loosdrecht A, Ogata K, Orfao A, Wells DA. Flow cytometry in myelodysplastic syndromes: Report from a working conference. Leuk Res 2008; 32: 517.
  • 3
    Loken MR, Wells DA. The role of flow cytometry in myelodysplastic syndromes. J Natl Comp Canc Netw 2008; 6: 935941.
  • 4
    Ogata K. Diagnostic flow cytometry for low-grade myelodysplastic syndromes. Hematol Oncol 2008; 26: 193198.
  • 5
    van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Drager AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, et al. Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 2009; 94: 11241134.
  • 6
    Della Porta MG, Lanza F, Del Vecchio L. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia. Cytometry B Clin Cytom 2011; 80B: 201211.
  • 7
    Ogata K, Della Porta MG, Malcovati L, Picone C, Yokose N, Matsuda A, Yamashita T, Tamura H, Tsukada J, Dan K. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: A prospective validation study. Haematologica 2009; 94: 10661074.
  • 8
    Ogata K, Kishikawa Y, Satoh C, Tamura H, Dan K, Hayashi A. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 2006; 108: 10371044.
  • 9
    Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang SA. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res 2008; 32: 215224.
  • 10
    Truong F, Smith BR, Stachurski D, Cerny J, Medeiros LJ, Woda BA, Wang SA. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: A prospective study. Leuk Res 2009; 33: 10391046.
  • 11
    van de Loosdrecht AA, Westers TM, Westra AH, Drager AM, van der Velden VH, Ossenkoppele GJ. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 2008; 111: 10671077.
  • 12
    Xu F, Li X, Wu L, He Q, Zhang Z, Chang C. Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes. Br J Haematol 2010; 149: 587597.
  • 13
    Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U, Greenberg P, Haferlach T, Haase D, Kolb HJ, Krieger O, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 2007; 31: 727736.
  • 14
    Kussick SJ, Wood BL. Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med 2003; 127: 11401147.
  • 15
    Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990; 2: 229240.
  • 16
    Bowen KL, Davis BH. Abnormal patterns of expression of CD16 (FcRgammaIII) and CD11b (CRIII) antigens by developing neutrophils in the bone marrow of patients with myelodysplastic syndrome. Lab Hematol 1997; 3: 292298.
  • 17
    Stetler-Stevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001; 98: 979987.
  • 18
    Kern W, Haferlach C, Schnittger S, Haferlach T. Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: Correlation to cytomorphology, cytogenetics, and clinical data. Cancer 2010; 116: 45494563.
  • 19
    Lorand-Metze I, Ribeiro E, Lima CS, Batista LS, Metze K. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res 2007; 31: 147155.
  • 20
    Matarraz S, Lopez A, Barrena S, Fernandez C, Jensen E, Flores-Montero J, Rasillo A, Sayagues JM, Sanchez ML, Barcena P, et al. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on A series of 56 patients. Cytometry B Clin Cytom 2010; 78B: 154168.
  • 21
    Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003; 102: 394403.
  • 22
    Brunning RD, Orazi A, Germing U, Le Beau MM, Porwit A, Baumann I, Vardiman J, Hellstrom-Lindberg E. Myelodysplastic syndromes. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 87108.
  • 23
    Bain BJ. The bone marrow aspirate of healthy subjects. Br J Haematol 1996; 94: 206209.
  • 24
    Matsuda A, Jinnai I, Yagasaki F, Kusumoto S, Minamihisamatsu M, Honda S, Murohashi I, Bessho M, Hirashima K. Refractory anemia with severe dysplasia: Clinical significance of morphological features in refractory anemia. Leukemia 1998; 12: 482485.
  • 25
    Ramos F, Fernandez-Ferrero S, Suarez D, Barbon M, Rodriguez JA, Gil S, Megido M, Ciudad J, Lopez N, del Canizo C, et al. Myelodysplastic syndrome: a search for minimal diagnostic criteria. Leuk Res 1999; 23: 283290.
  • 26
    Vardiman JW. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes. In: Burns LJ, Mikhael JR, Schwartz Bs, Crowther MA, editors. Hematology: American Society of Hematology Education Program. American Society of Hematology; 2006. pp 199204.
  • 27
    Verburgh E, Achten R, Louw VJ, Brusselmans C, Delforge M, Boogaerts M, Hagemeijer A, Vandenberghe P, Verhoef G. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. Leukemia 2007; 21: 668677.
  • 28
    Fujimoto H, Sakata T, Hamaguchi Y, Shiga S, Tohyama K, Ichiyama S, Wang FS, Houwen B. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations. Cytometry 2000; 42: 371378.
  • 29
    Elghetany MT, Davis BH. Impact of preanalytical variables on granulocytic surface antigen expression: A review. Cytometry B Clin Cytom 2005; 65B: 15.
  • 30
    Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 1994; 153: 12541263.
  • 31
    Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995; 85: 532540.
  • 32
    Nusbaum P, Laine C, Seveau S, Lesavre P, Halbwachs-Mecarelli L. Early membrane events in polymorphonuclear cell (PMN) apoptosis: Membrane blebbing and vesicle release, CD43 and CD16 down-regulation and phosphatidylserine externalization. Biochem Soc Trans 2004; 32: 477479.
  • 33
    Carter PH, Resto-Ruiz S, Washington GC, Ethridge S, Palini A, Vogt R, Waxdal M, Fleisher T, Noguchi PD, Marti GE. Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations. Cytometry 1992; 13: 6874.
  • 34
    Hodge GL, Flower R, Han P. Optimal storage conditions for preserving granulocyte viability as monitored by Annexin V binding in whole blood. J Immunol Methods 1999; 225: 2738.
  • 35
    Clinical flow cytometric analysis of neoplastic hematolymphoid cells; approved guideline- 2nd ed. CLSI Document H43-A2 [ISBN 1-56238-635-2]. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania 19087–1898, USA 2007.
  • 36
    Forsyth KD, Levinsky RJ. Preparative procedures of cooling and re-warming increase leukocyte integrin expression and function on neutrophils. J Immunol Methods 1990; 128: 159163.
  • 37
    Arnoulet C, Bene MC, Durrieu F, Feuillard J, Fossat C, Husson B, Jouault H, Maynadie M, Lacombe F. Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: a reference document based on a systematic approach by the GTLLF and GEIL. Cytometry B Clin Cytom 2010; 78B: 410.
  • 38
    Bzowska M, Hamczyk M, Skalniak A, Guzik K. Rapid decrease of CD16 (FcgammaRIII) expression on heat-shocked neutrophils and their recognition by macrophages. J Biomed Biotech 2011; 2011: 284759.
  • 39
    Elbim C, Estaquier J. Cytokines modulate neutrophil death. European cytokine network 2010; 21: 16.
  • 40
    Garlichs CD, Eskafi S, Cicha I, Schmeisser A, Walzog B, Raaz D, Stumpf C, Yilmaz A, Bremer J, Ludwig J, et al. Delay of neutrophil apoptosis in acute coronary syndromes. J Leukoc Biol 2004; 75: 828835.
  • 41
    Wagner C, Deppisch R, Denefleh B, Hug F, Andrassy K, Hansch GM. Expression patterns of the lipopolysaccharide receptor CD14, and the FCgamma receptors CD16 and CD64 on polymorphonuclear neutrophils: Data from patients with severe bacterial infections and lipopolysaccharide-exposed cells. Shock 2003; 19: 512.
  • 42
    Wittmann S, Rothe G, Schmitz G, Frohlich D. Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response. Cytometry A 2004; 57A: 5362.
  • 43
    Finn WG, Harrington AM, Carter KM, Raich R, Kroft SH, Hero AO 3rd. Immunophenotypic signatures of benign and dysplastic granulopoiesis by cytomic profiling. Cytometry B Clin Cytom 2011; 80B: 282290.
  • 44
    Elghetany MT, Ge Y, Patel J, Martinez J, Uhrova H. Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: Correlation with morphologic assessments. J Clin Lab Anal 2004; 18: 3641.
  • 45
    Vikentiou M, Psarra K, Kapsimali V, Liapis K, Michael M, Tsionos K, Lianidou E, Papasteriades C. Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes. Leuk Lymphoma 2009; 50: 401409.